October 15, 2025

Novo Nordisk to Pay Omeros Up to $2.1 Billion For Blood Disease Drug

pgnnivash34@gmail.com October 15, 2025 0
Novo Nordisk to Pay Omeros Up to .1 Billion For Blood Disease Drug

Under the agreement, Novo Nordisk will be granted exclusive global rights to develop and commercialize zaltenibart.



Source link

About The Author

pgnnivash34@gmail.com

See author's posts

More Stories

Actress ignored subtle cancer symptom for years before collapsing onstage

Actress ignored subtle cancer symptom for years before collapsing onstage

pgnnivash34@gmail.com October 15, 2025 0
Hims & Hers to Offer Treatments for Menopause, Perimenopause

Hims & Hers to Offer Treatments for Menopause, Perimenopause

pgnnivash34@gmail.com October 15, 2025 0
Stealth breast cancer that hides from scans targeted in breakthrough tech

Stealth breast cancer that hides from scans targeted in breakthrough tech

pgnnivash34@gmail.com October 15, 2025 0

Leave a Reply

Your email address will not be published. Required fields are marked *